Envision Pharma Group Acquires 90TEN

April 8, 2020

Envision Pharma Group, a portfolio company backed by Ardian and GHO Capital, has acquired London-based healthcare communications consultancy 90TEN. 90TEN will retain its brand and management, bringing behavioral science-led communications capabilities to Envision's global medical affairs and communications offerings.

Buyers
Envision Pharma Group, Ardian, GHO Capital Partners LLP
Targets
90TEN
Platforms
Envision Pharma Group
Location
England, United Kingdom
Transaction Type
Addon

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.